Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Hepatocellular Carcinoma Stage III”

231 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 231 results

Large-scale testing (Phase 3)Active Not RecruitingNCT05904886
What this trial is testing

A Study Evaluating Atezolizumab and Bevacizumab, With or Without Tiragolumab, in Participants With Untreated Locally Advanced or Metastatic Hepatocellular Carcinoma (HCC) (IMbrave152)

Who this might be right for
Hepatocellular Carcinoma
Hoffmann-La Roche 687
Large-scale testing (Phase 3)Study completedNCT00692770
What this trial is testing

Sorafenib as Adjuvant Treatment in the Prevention Of Recurrence of Hepatocellular Carcinoma (STORM)

Who this might be right for
Carcinoma, Hepatocellular
Bayer 1,114
Large-scale testing (Phase 3)Ended earlyNCT01108705
What this trial is testing

Comparison of Brivanib and Best Supportive Care (BSC) With Placebo and BSC for Treatment of Liver Cancer in Asian Patients Who Have Failed Sorafenib Treatment

Who this might be right for
Carcinoma, Hepatocellular
Bristol-Myers Squibb 87
Testing effectiveness (Phase 2)Study completedNCT00807300
What this trial is testing

Computed Tomography (CT) - Guided Brachytherapy Versus Transarterial Chemoembolization in Patients With Unresectable Hepatocellular Carcinoma

Who this might be right for
Hepatocellular Carcinoma
University of Magdeburg 77
Early research (Phase 1)Study completedNCT00083213
What this trial is testing

Intravenous VEGF Trap in Treating Patients With Relapsed or Refractory Advanced Solid Tumors or Non-Hodgkin's Lymphoma

Who this might be right for
Cancer
Regeneron Pharmaceuticals 25
Large-scale testing (Phase 3)Study completedNCT01265810
What this trial is testing

Caphosol in Oral Mucositis Due to Targeted Therapy

Who this might be right for
Oral ComplaintsRenal Cell CarcinomaHepatocellular Carcinoma+1 more
Impaqtt Foundation 64
Early research (Phase 1)Study completedNCT00654160
What this trial is testing

Irinotecan, Fluorouracil, and Leucovorin in Treating Patients With Advanced Gastrointestinal Cancer

Who this might be right for
Anal CancerCarcinoma of the AppendixColorectal Cancer+9 more
Mayo Clinic 7
Large-scale testing (Phase 3)Not Yet RecruitingNCT07823348
What this trial is testing

JS207 Plus JS007 Versus Toripalimab Plus Bevacizumab as First-Line Treatment for Advanced Liver Cancer

Who this might be right for
Hepatocellular Carcinoma
Shanghai Junshi Bioscience Co., Ltd. 560
Large-scale testing (Phase 3)Study completedNCT00386984
What this trial is testing

Hector-Study to Evaluate the Efficacy of Octreotide in Patients With Inoperable Hepatocellular Carcinoma

Who this might be right for
Carcinoma, Hepatocellular
University Hospital Freiburg 108
Large-scale testing (Phase 3)Looking for participantsNCT05738616
What this trial is testing

Lenvatinib Combined With TACE and Camrelizumab in Conversion Resection for Advanced Hepatocellular Carcinoma (LEN-TAC Study)

Who this might be right for
Advanced Hepatocellular Carcinoma
Wen Tianfu 196
Large-scale testing (Phase 3)Not Yet RecruitingNCT06841185
What this trial is testing

Compare the Efficacy, Safety, Immunogenicity, and Pharmacokinetic Profile of HLX13 with YERVOY As a First-Line Treatment for Patients with Unresectable Hepatocellular Carcinoma

Who this might be right for
Hepatocellular Carcinoma (HCC)
Shanghai Henlius Biotech 656
Large-scale testing (Phase 3)Ended earlyNCT04985136
What this trial is testing

Camrelizumab Combined With Rivoceranib Mesylate Versus Investigator's Choice of Regimen in Treatment of Patients With Advanced Hepatocellular Carcinoma (HCC)

Who this might be right for
Advanced Hepatocellular Carcinoma (HCC)
Jiangsu HengRui Medicine Co., Ltd. 1
Large-scale testing (Phase 3)Active Not RecruitingNCT05320692
What this trial is testing

TACE Combined With Camrelizumab Plus Rivoceranib (Apatinib) in Patients With Incurable Hepatocellular Carcinoma

Who this might be right for
Hepatocellular Carcinoma
Jiangsu HengRui Medicine Co., Ltd. 423
Large-scale testing (Phase 3)Temporarily pausedNCT04268888
What this trial is testing

Nivolumab in Combination With TACE/TAE for Patients With Intermediate Stage HCC

Who this might be right for
Hepatocellular Carcinoma
The Clatterbridge Cancer Centre NHS Foundation Trust 522
Large-scale testing (Phase 3)Study completedNCT01164202
What this trial is testing

Chemoembolization of the Liver With or Without Sunitinib Malate in Treating Patients With Liver Cancer

Who this might be right for
Liver Cancer
Federation Francophone de Cancerologie Digestive 78
Not applicableStudy completedNCT00477919
What this trial is testing

E-MOSAIC Electronic Tool to Monitor Symptoms

Who this might be right for
Cancer
Swiss Cancer Institute 264
Large-scale testing (Phase 3)Ended earlyNCT00225290
What this trial is testing

Phase III Trial of Oral Thalidomide in Advanced Hepatocellular Carcinoma With Poor Liver Reserve

Who this might be right for
Carcinoma, Hepatocellular
TTY Biopharm 230
Large-scale testing (Phase 3)UnknownNCT01324076
What this trial is testing

Transarterial Chemoembolization Using Doxorubicin Beads With or Without Sorafenib Tosylate in Treating Patients With Liver Cancer That Cannot Be Removed By Surgery

Who this might be right for
Liver Cancer
University College, London 412
Early research (Phase 1)Study completedNCT00002854
What this trial is testing

High-Dose Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Advanced Cancer

Who this might be right for
Cancer
City of Hope Medical Center 33
Large-scale testing (Phase 3)Looking for participantsNCT03368651
What this trial is testing

The Impact on Survival of Neo-adjuvant Transarterial Chemoinfusion (TAI) for Patients With Hepatocellular Carcinoma And Portal Vein Tumor Thrombosis (PVTT) Who Underwent Hepatectomy : A Random, Controlled, Stage III Clinical Trial.

Who this might be right for
Hepatocellular Carcinoma
Sun Yat-sen University 230
Next Page